HOLOGIC INC (HOLX) Stock Fundamental Analysis
NASDAQ:HOLX - Nasdaq - US4364401012 - Common Stock - Currency: USD
HOLX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. HOLX gets an excellent profitability rating and is at the same time showing great financial health properties. HOLX has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
HOLX had positive earnings in the past year.
HOLX had a positive operating cash flow in the past year.
HOLX had positive earnings in each of the past 5 years.
Each year in the past 5 years HOLX had a positive operating cash flow.
1.2 Ratios
HOLX has a better Return On Assets (6.51%) than 88.24% of its industry peers.
HOLX has a better Return On Equity (12.05%) than 88.24% of its industry peers.
With an excellent Return On Invested Capital value of 10.33%, HOLX belongs to the best of the industry, outperforming 92.51% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HOLX is above the industry average of 7.89%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.51% | ||
| ROE | 12.05% | ||
| ROIC | 10.33% |
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
1.3 Margins
HOLX has a Profit Margin of 13.83%. This is amongst the best in the industry. HOLX outperforms 91.44% of its industry peers.
HOLX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 24.43%, HOLX belongs to the top of the industry, outperforming 94.65% of the companies in the same industry.
In the last couple of years the Operating Margin of HOLX has grown nicely.
HOLX has a Gross Margin of 56.44%. This is comparable to the rest of the industry: HOLX outperforms 55.08% of its industry peers.
HOLX's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.43% | ||
| PM (TTM) | 13.83% | ||
| GM | 56.44% |
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HOLX is still creating some value.
The number of shares outstanding for HOLX has been reduced compared to 1 year ago.
Compared to 5 years ago, HOLX has less shares outstanding
The debt/assets ratio for HOLX has been reduced compared to a year ago.
2.2 Solvency
HOLX has an Altman-Z score of 3.86. This indicates that HOLX is financially healthy and has little risk of bankruptcy at the moment.
HOLX's Altman-Z score of 3.86 is fine compared to the rest of the industry. HOLX outperforms 73.80% of its industry peers.
The Debt to FCF ratio of HOLX is 2.61, which is a good value as it means it would take HOLX, 2.61 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of HOLX (2.61) is better than 89.30% of its industry peers.
HOLX has a Debt/Equity ratio of 0.54. This is a neutral value indicating HOLX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.54, HOLX is not doing good in the industry: 65.24% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.54 | ||
| Debt/FCF | 2.61 | ||
| Altman-Z | 3.86 |
ROIC/WACC1.24
WACC8.32%
2.3 Liquidity
HOLX has a Current Ratio of 3.24. This indicates that HOLX is financially healthy and has no problem in meeting its short term obligations.
HOLX's Current ratio of 3.24 is in line compared to the rest of the industry. HOLX outperforms 57.75% of its industry peers.
HOLX has a Quick Ratio of 2.52. This indicates that HOLX is financially healthy and has no problem in meeting its short term obligations.
With a Quick ratio value of 2.52, HOLX perfoms like the industry average, outperforming 57.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.24 | ||
| Quick Ratio | 2.52 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 7.83% over the past year.
HOLX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.83% yearly.
HOLX shows a small growth in Revenue. In the last year, the Revenue has grown by 1.66%.
Measured over the past years, HOLX shows a small growth in Revenue. The Revenue has been growing by 3.66% on average per year.
EPS 1Y (TTM)7.83%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%0%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%-1.23%
3.2 Future
The Earnings Per Share is expected to grow by 5.71% on average over the next years.
Based on estimates for the next years, HOLX will show a small growth in Revenue. The Revenue will grow by 4.75% on average per year.
EPS Next Y4.52%
EPS Next 2Y6.03%
EPS Next 3Y7.34%
EPS Next 5Y5.71%
Revenue Next Year1.24%
Revenue Next 2Y3.06%
Revenue Next 3Y3.78%
Revenue Next 5Y4.75%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
HOLX is valuated correctly with a Price/Earnings ratio of 15.78.
HOLX's Price/Earnings ratio is rather cheap when compared to the industry. HOLX is cheaper than 82.89% of the companies in the same industry.
When comparing the Price/Earnings ratio of HOLX to the average of the S&P500 Index (26.32), we can say HOLX is valued slightly cheaper.
With a Price/Forward Earnings ratio of 14.21, HOLX is valued correctly.
HOLX's Price/Forward Earnings ratio is rather cheap when compared to the industry. HOLX is cheaper than 83.96% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of HOLX to the average of the S&P500 Index (22.13), we can say HOLX is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.78 | ||
| Fwd PE | 14.21 |
4.2 Price Multiples
87.17% of the companies in the same industry are more expensive than HOLX, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HOLX indicates a rather cheap valuation: HOLX is cheaper than 90.91% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.97 | ||
| EV/EBITDA | 11.83 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HOLX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.49
PEG (5Y)1.46
EPS Next 2Y6.03%
EPS Next 3Y7.34%
5. Dividend
5.1 Amount
HOLX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
65.18
+0.43 (+0.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners102.68%
Inst Owner Change-2.29%
Ins Owners0.78%
Ins Owner Change0.4%
Market Cap14.53B
Analysts70
Price Target68.28 (4.76%)
Short Float %3.28%
Short Ratio1.86
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.62%
Min EPS beat(2)-0.63%
Max EPS beat(2)-0.62%
EPS beat(4)1
Avg EPS beat(4)-0.3%
Min EPS beat(4)-2.26%
Max EPS beat(4)2.31%
EPS beat(8)5
Avg EPS beat(8)1.16%
EPS beat(12)9
Avg EPS beat(12)8.52%
EPS beat(16)13
Avg EPS beat(16)16.77%
Revenue beat(2)0
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-2.22%
Max Revenue beat(2)-1.44%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.22%
Max Revenue beat(4)-0.84%
Revenue beat(8)2
Avg Revenue beat(8)-0.77%
Revenue beat(12)6
Avg Revenue beat(12)1.68%
Revenue beat(16)10
Avg Revenue beat(16)5.33%
PT rev (1m)-2.08%
PT rev (3m)-17.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.12%
EPS NY rev (1m)0%
EPS NY rev (3m)-2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.01%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.41%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.78 | ||
| Fwd PE | 14.21 | ||
| P/S | 3.61 | ||
| P/FCF | 14.97 | ||
| P/OCF | 12.84 | ||
| P/B | 3.14 | ||
| P/tB | 45.26 | ||
| EV/EBITDA | 11.83 |
EPS(TTM)4.13
EY6.34%
EPS(NY)4.59
Fwd EY7.04%
FCF(TTM)4.35
FCFY6.68%
OCF(TTM)5.08
OCFY7.79%
SpS18.07
BVpS20.73
TBVpS1.44
PEG (NY)3.49
PEG (5Y)1.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.51% | ||
| ROE | 12.05% | ||
| ROCE | 13.02% | ||
| ROIC | 10.33% | ||
| ROICexc | 13.15% | ||
| ROICexgc | 47.7% | ||
| OM | 24.43% | ||
| PM (TTM) | 13.83% | ||
| GM | 56.44% | ||
| FCFM | 24.09% |
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
ROICexc(3y)16.74%
ROICexc(5y)19.65%
ROICexgc(3y)75.27%
ROICexgc(5y)85.91%
ROCE(3y)14.69%
ROCE(5y)19.22%
ROICexcg growth 3Y-27.14%
ROICexcg growth 5Y-3.18%
ROICexc growth 3Y-24.3%
ROICexc growth 5Y7.08%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
F-Score8
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.54 | ||
| Debt/FCF | 2.61 | ||
| Debt/EBITDA | 1.93 | ||
| Cap/Depr | 54.33% | ||
| Cap/Sales | 4.01% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 88.34% | ||
| Profit Quality | 174.26% | ||
| Current Ratio | 3.24 | ||
| Quick Ratio | 2.52 | ||
| Altman-Z | 3.86 |
F-Score8
WACC8.32%
ROIC/WACC1.24
Cap/Depr(3y)40.46%
Cap/Depr(5y)40.59%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.37%
Profit Quality(3y)165.37%
Profit Quality(5y)135.66%
High Growth Momentum
Growth
EPS 1Y (TTM)7.83%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%0%
EPS Next Y4.52%
EPS Next 2Y6.03%
EPS Next 3Y7.34%
EPS Next 5Y5.71%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%-1.23%
Revenue Next Year1.24%
Revenue Next 2Y3.06%
Revenue Next 3Y3.78%
Revenue Next 5Y4.75%
EBIT growth 1Y11.01%
EBIT growth 3Y-26.89%
EBIT growth 5Y11.29%
EBIT Next Year13.56%
EBIT Next 3Y8.09%
EBIT Next 5Y6.92%
FCF growth 1Y15.42%
FCF growth 3Y-19.16%
FCF growth 5Y16.4%
OCF growth 1Y17.99%
OCF growth 3Y-17.99%
OCF growth 5Y14.62%